Clinical trials
Completed Phase 2 Supranuclear Palsy, Progressive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GemVax & Kael | 2 |
| AlzProtect SAS | 1 |
| EmeraMed | 1 |
| German Parkinson Study Group (GPS) | 1 |
| Nantes University Hospital | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Transposon Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Supranuclear Palsy, Progressive | 8 |
| Multiple System Atrophy | 1 |
| Neurodegenerative Diseases | 1 |
| Parkinsonian Disorders | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.